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Preventing delayed diagnosis of cancer: 
clinicians’ views on main problems and solutions
Background Delayed diagnosis is a major contributing factor to the 
UK’s lower cancer survival compared to many European countries. 
In the UK, there is a significant national variation in early cancer di-
agnosis. Healthcare providers can offer an insight into local priorities 
for timely cancer diagnosis. In this study, we aimed to identify the 
main problems and solutions relating to delay cancer diagnosis ac-
cording to cancer care clinicians.
Methods We developed and implemented a new priority–setting ap-
proach called PRIORITIZE and invited North West London cancer 
care clinicians to identify and prioritize main causes for and solutions 
to delayed diagnosis of cancer care.
Results Clinicians identified a number of concrete problems and so-
lutions relating to delayed diagnosis of cancer. Raising public aware-
ness, patient education as well as better access to specialist care and 
diagnostic testing were seen as the highest priorities. The identified 
suggestions focused mostly on the delays during referrals from pri-
mary to secondary care.
Conclusions Many identified priorities were feasible, affordable and 
converged around common themes such as public awareness, care 
continuity and length of consultation. As a timely, proactive and scal-
able priority–setting approach, PRIORITZE could be implemented as 
a routine preventative system for determining patient safety issues by 
frontline staff.
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Timely cancer diagnosis improves patient survival and quality of life [1]. 
Delayed diagnosis is a major contributing factor to lower cancer survival 
in the UK compared to a number of European countries [2,3]. The out-
comes of an 1 in 3 people in the UK, estimated to develop cancer during 
their lifetime, are significantly affected by a large national variation in time-
ly cancer diagnosis [4,5]. Delayed cancer diagnosis accounts for 5 to 10 
000 premature deaths in England and an extra Ł150 million of the NHS 
spending annually [2,6].
In the UK, primary care providers play an important role in cancer care 
pathway as the first point of contact for patients. Cancer is mostly diag-
nosed on presentation to primary care, upon screening as an incidental 
finding or after an emergency presentation [5]. Patients diagnosed in pri-
mary care are referred to specialists for further diagnostic workup and 
treatment. Diagnostic delays occur because of late patient presentation, 
problems at the primary (from presentation to referral) or secondary care 
V
IE
W
PO
IN
TS
PA
PE
RS
Tudor Car et al.
level (from referral to final diagnosis) and during screening 
[7].
Delayed diagnosis of cancer has been extensively re-
searched, particularly with the launch of “Evidence for a 
National Awareness and Early Diagnosis Initiative” (NAE-
DI) [5]. However, the UK is still faced with significant re-
gional differences in timely cancer diagnosis [8]. A nation-
wide, consistent implementation of available evidence 
alone could lead to a better chance of survival in 20 000 
people [8]. Regional differences in the UK cancer outcomes 
call for safety policies informed by a local prioritization of 
the effective interventions. Although existing research iden-
tifies a number of contributing factors to delayed cancer 
diagnosis, it is unclear which patient safety interventions 
would have the highest yield and should be given prece-
dence. Clinicians offer unmatched, first–hand insight into 
the health care service delivery and can help in establish-
ing a consensus on priorities for timely cancer diagnosis 
[9–11]. Furthermore, clinicians’ engagement is essential for 
successful implementation of patient safety interventions. 
The UK’s new national patient safety programme and the 
recent Institute of Medicine report on improving diagnosis 
in health care call for the inclusion of clinicians in identify-
ing high–priority areas for patient safety and timely diag-
nosis. [12,13]. In this study, we aimed to identify cancer 
care clinicians’ priorities for prevention of delayed diagno-
sis of cancer in North West London.
METHODS
We adopted a definition for delayed diagnosis as “a diag-
nosis that was unintentionally delayed while sufficient in-
formation was available earlier” [14].
We developed and implemented the PRIORITIZE method, 
an adaptation of the Child Health and Nutrition Research 
Initiative (CHNRI) approach, to determine the main prob-
lems and solutions relating to delayed diagnosis of cancer 
[15–17] (Figure 1). The CHNRI methodology invites in-
ternational research experts to nominate priorities for re-
search and has been used extensively to inform policymak-
ers, funding bodies and international organizations. 
PRIORITIZE is designed to reveal priorities for health care 
services delivery as seen by clinicians using two comple-
mentary angles: problems and solutions. The final output 
of this approach is presentation of the top priorities catego-
rized according to level of implementation: a) actions for 
clinicians b) actions for health care organisations and c) ac-
tions for health system custodians (Figure 1). This study 
is a service evaluation as well as a quality and safety im-
provement initiative and therefore did not require ethics or 
governance approval according to the UK’s Health Research 
Authority guidance [18,19].
At the study outset, the project steering group (Imperial 
College Health Partners’ Patient Safety Board) decided to 
focus on two topics relating to cancer care patient safety: 
medication safety and delayed diagnosis. This paper de-
scribes the findings related to delayed diagnosis of cancer. 
The project steering group also determined the most per-
tinent criteria to guide the prioritisation of the collated sug-
gestions, ie, scoring of problems and solutions (Box 1).
In the first phase of the study, we developed an open–end-
ed questionnaire for clinicians to identify the main prob-
lems and solutions relating to delayed diagnosis in cancer 
care. The questionnaire was piloted on a smaller sample of 
primary care physicians and trainees and amended accord-
ingly. The final questionnaire was distributed in both pa-
per–based and online version and disseminated via email 
lists, snowballing (participants were asked to forward the 
survey to colleagues), and visits to several general practic-
es in North West London (Text S1 in Online Supplemen-
tary Document). We targeted oncology consultants, gen-
eral practitioners, trainees, nurses and pharmacists. The 
collected ideas were examined using content analysis with 
open coding to categorise the free–text responses. Suffi-
Figure 1. PRIORITIZE methodology flow diagram
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ciently similar suggestions were merged and collated into 
composite set of priorities.
In the second phase, we created a prioritization matrix con-
sisting of collated priorities and statements outlining priori-
tization criteria (Box 1 and Text S2 in Online Supplemen-
tary Document). Next, we invited clinicians to categorize 
the priorities according to the prioritization criteria using 
four options: score of 1 for ‘Yes – I agree with this statement’, 
score of 0 for ‘No – I do not agree with this statement’, score 
of 0.5 for ‘Unsure – I am unsure whether or not I agree’ and 
no score (blank) for ‘Unaware – I do not feel sufficiently fa-
miliar or confident to score this suggestion’ (Text S2 in On-
line Supplementary Document). As the scoring process 
took about an hour to complete, we offered a token payment 
to the participants in a form of a GBP 50 voucher. From the 
initial cohort of primary care clinicians, we arbitrarily invit-
ed clinicians to perform scoring of the priorities.
The scores for the suggested priorities were computed as 
the mean of scores for each of the criteria (ie, five criteria 
for problems and three for solutions) and ranged from 0 to 
100. The Kappa statistic was deemed an inappropriate test 
to determine inter–rater agreement in this study due to the 
sample size, the non–standardised categorical nature of 
data, the option of blank response to some statements and 
the number of our different criteria used for scoring. In-
stead, we evaluated the inter–rater agreement using the av-
erage expert agreement (AEA). The AEA is the proportion 
of scorers selecting the mode (the most common score) for 
each research question. The AEA does not provide infor-
mation on statistical significance of any differences between 
scorers, but is pertinent to decision makers as it gives an 
indication of the degree of agreement between clinicians in 
terms of priorities. The AEA was calculated using the follow-
ing formula (Figure 2), where q is a question that experts 
are being asked to evaluate competing patient safety threats 
(in this case problems leading to delayed diagnosis of can-
cer), ranging from 1 to 5 for problems and 1 to 3 for solu-
tions.
Box 1. Scoring criteria for prioritization of collated suggestions
For problems
Frequency: This patient safety threat is common
Severity: This patient safety threat leads to high rates of 
mortality, morbidity and incapacity
Inequity: This patient safety threat affects lower socio-eco-
nomic groups or ethnic minorities more than other groups
Economic impact: The consequences of this patient safety 
threat are costly to the health care system
Responsiveness to solution: This incident is amenable to 
a solution within 5 years
For solutions
Feasibility: The implementation of this solution is feasible
Cost–effectiveness: This solution is cost–effective
Potential for saving lives: This solution would save lives
Figure 3. The primary care cancer pathway in the UK (based on 
“National Patient Safety Agency. Delayed diagnosis of cancer: 
thematic review, 2010”).
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Figure 2. Formula for calculating average experts agreement; q 
is a question that experts’ are being asked to evaluate competing 
patient safety threats.
Diagnosis is a multistep process that is influenced by the 
provider, the patient and the health system [20,21]. In ac-
cordance with the patient cancer care pathway in the UK 
developed by the National Patient Safety Agency (Figure 3), 
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we employed an adapted version of a four–dimension mod-
el of delays in cancer diagnosis consisting of: 1. Patient delay 
– from the onset of symptoms to patients’ first presentation, 
2. Primary care delay – from the first presentation in pri-
mary care to the referral for further care or diagnostic in-
vestigation, 3. Referral delay – from the referral for further 
care or diagnostic investigation to being seen in secondary 
care, 4. Secondary care delay – from being first seen in sec-
ondary care to diagnosis and 5. Screening delay – from be-
ing screen to being diagnosed [22,23]. In our analysis, we 
used an extensively referenced framework categorizing the 
diagnostic errors into system, cognitive and patient–related 
factors [14,24]. In addition, solutions were categorized in 
terms of the type of organizational interventions to decrease 
the diagnostic errors they addressed, ie, technique, person-
nel changes, staff educational interventions, structured pro-
cess changes, technology–based intervention and addition-
al review (Text S3 in Online Supplementary Document) 
[25]. To this framework, we added an additional category 
focused on patient education and empowerment.
RESULTS
In the first phase, we invited >780 cancer care clinicians 
and received 40 completed questionnaires, mostly by on-
cology consultants (n = 15, 37.5%) and trainees (n = 15, 
37.5%) (Text S4 in Online Supplementary Document). 
93 problems and 65 solutions relating to delayed diagnosis 
were thematically merged into a set of 21 distinct problems 
and 19 solutions. In the second phase, we invited 415 can-
er care clinicians from the initial cohort to score the com-
posite list of suggestions and received 26 fully completed 
scoring sheets (Figure 4).
The top ranked problems leading to delayed diagnosis of 
cancer according to clinicians are lack of patient awareness 
of cancer symptoms, poor continuity of care and delays in 
referrals to secondary care (Table 1). The highest ranked 
solutions to delayed cancer diagnosis are public awareness 
campaigns on common symptoms of cancer, better adher-
ence to referral guidelines and improved communication 
between general and oncology teams in hospitals (Table 2).
Most of the top ten problems addressed system–level issues 
and organization of care (eg, lack of care continuity, short 
GP consultations leading to inappropriate history taking 
and examination, delays in ordering and processing refer-
rals and poor access to diagnostic testing) (Table 1). Clini-
cians considered referrals from primary to secondary care 
as the most liable to the problems leading to delayed can-
cer diagnosis (Table S5 in Online Supplementary Docu-
ment).
Patients’ lack of cancer symptom awareness and the conse-
quent late presentation, poor continuity of care and referral 
delays were considered top problems leading to delayed di-
agnosis in cancer care (Table S5 in Online Supplementary 
Document). Patients from lower socio–economic groups or 
ethnic minorities were considered most likely to use other 
health care services not designed to diagnose cancer. Pro-
posed cognitive–related problems focused mostly on GPs 
ignoring or overlooking cancer alarm symptoms due to pa-
tients’ comorbidities, an unusual presentation and in pa-
tients with the low risk of cancer. Clinicians considered 
diagnostic lapses by midwifes, introduction of lower–
threshold referrals and more inclusive screening as least 
important problems leading to delayed diagnosis of cancer. 
Errors at the hospital system level, such as referrals being 
lost or misallocated were also ranked very low.
Overall, proposed solutions focused on the organisational 
changes with the aim of improving the referral process and 
the access to diagnostic testing as well as educational inter-
ventions aimed primarily at general practitioners (Table S6 
in Online Supplementary Document). The most cost-
effective solutions according to the clinicians are public 
awareness campaigns on common symptoms of cancer to 
ensure early presentation. Rapid referrals from primary care 
to hospitals were considered a solution most likely to save 
lives. The most feasible solution according to clinicians are 
longer consultations to ensure full examination and his-
Figure 4. Participants’ flow diagram.
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Table 1. Clinicians–identified top ten problems leading to delayed diagnosis of cancer*
Rank PRoPosed PRoblem leading to delayed diagnosis of canceR caRe PRioRity 
scoRe
tyPe of factoR leading 
to diagnostic eRRoR
tyPe of delay to canceR 
diagnosis
1 Lack of patient awareness of cancer symptoms mean that they do not attend for advice and 
investigation in a timely manner
82.5 Patient–related Patient delay
2 Poor continuity of care for patients leads to symptoms being missed and delayed diagnosis 79 System Patient delay
3 Delays in referrals eg, GPs not following two–week referral guidelines mean that patients are 
diagnosed late in the course of the disease
79 System Referral delay
4 Patients not having a GP mean that they may use other services such as the Emergency 
Department which are not designed to detect or diagnose cancer and hence present late
78 Patient–related Patient delay
5 GPs not having enough time mean that they do not take a full history or examine patients 
fully and miss cancers
78 System Primary care delay
6 Delays in accessing diagnostics in the community mean that patients wait longer for hospital 
appointments
76.5 System Referral delay
7 Patient fears of the diagnosis of cancer mean that they do not seek health advice early in the 
course of their illness
75 Patient–related Patient delay
8 Inefficient processes and bureaucracy in hospitals leads to delays in processing referrals and 
arranging appointments
69.5 System Referral delay
9 Co–morbidities make it more difficult to diagnose cancer as the symptoms may be confused 
with those of other existing illnesses
68.5 Cognitive Primary care delay
10 GPs ignoring alarm symptoms eg, rectal bleeding leads to delays in diagnosis 68 Cognitive Primary care delay
*The table uses clinicians’ verbatim statements which were only exceptionally reworded for clarity. Clinicians scored problems using the following cri-
teria: frequency, severity, inequity, economic impact and responsiveness to solution (Box 1). The scoring options were 1 for “yes” (eg, this problem is 
common), 0 for “no” (eg, this problem is uncommon), 0.5 for “unsure” (eg, I am unsure if this problem is common) and blank for “unaware” (eg, I do 
not know if his problem is common). Total priority score is the mean of the scores for each of the five criteria and ranges from 0 to 100. Higher ranked 
problems received more “Yes” responses for each of the criteria and a higher score.
Table 2. Clinicians’ identified top 10 solutions for delayed diagnosis of cancer
Rank PRoPosed solution to delayed diagnosis of canceR PRioRity 
scoRe
categoRies of oRganizational 
inteRventions to 
decRease diagnostic eRRoRs
tyPe of delay the 
PRoPosed solution 
is aimed at
1 Encourage public awareness campaigns on common symptoms of cancer to ensure 
patients present early in the course of their disease
94.1 Patient education and 
empowerment
Patient delay
2 Improve adherence to referral guidelines to ensure earlier diagnosis 93.3 Educational intervention Referral delay
3 Improve communication between general and oncology teams in hospitals to improve the 
standard of care
93.3 Structured–process change Referral delay
4 Provide prompt feedback to primary care if delayed diagnosis to encourage learning about 
incidents
90 Educational interventions Primary care 
delay
5 Facilitate rapid referrals from primary care to hospitals 89.2 Structured–process change Referral delay
6 Improve specialist education for doctors and nurses to ensure better standards of care 89.2 Educational interventions Secondary 
care delay
7 Improve funding provided to improve services available and provide quicker access to 
diagnostics and specialists
87.5 Structured–process change Referral delay
8 Improve access to GPs for patients to ensure earlier diagnosis 85.8 Structured–process change Patient delay
9 Improve referral and follow up processes to ensure referrals are not lost 85.8 Structured–process change Referral delay
10 Ensure sufficient staff available to deal with referrals to ensure no delay in processing 
referrals
84.1 Personnel change Referral delay
The table uses clinicians’ verbatim statements which were only exceptionally reworded for clarity. Clinicians scored solutions using the following crite-
ria: feasibility, cost–effectiveness and potential for saving lives (Box 1). The scoring options were 1 for “yes” (eg, this problem is common), 0 for “no” (eg, 
this problem is uncommon), 0.5 for “unsure” (eg, I am unsure if this problem is common) and blank for “unaware” (eg, I do not know if his problem is 
common). Total priority score is the mean of the scores for each of the three criteria and ranges from 0 to 100. Higher ranked solutions received more 
“Yes” responses for each of the criteria and a higher score.
tory taking. The least important solutions to delayed cancer 
diagnosis according to clinicians are referring people with 
a family history of cancer regardless of their symptoms, 
mandating referral for certain symptoms and tracking pa-
tients who do not attend their hospital appointment.
The proposed problems and solutions were interrelated as 
the majority of the identified problems and solutions ad-
dressed referrals between primary and secondary care and 
the top priority in both types of suggestions relates to pub-
lic awareness of cancer (Figure 5). The highest ranked sug-
gestions had the highest AEA, ie, there was a stronger con-
sensus among the clinicians regarding to the top suggestions 
compared to those ranked lower. The lowest ranked sug-
gestions received a significant number of “Unsure” and 
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“Unaware” answers through scoring (Table S5 in Online 
Supplementary Document).
DISCUSSION
Cancer care clinicians in our study identified a range of 
priorities for timely diagnosis of cancer in North West Lon-
don. Lack of cancer symptom recognition among patients, 
poor continuity of care and complex patient presentation 
were seen as top problems. Raising public awareness, bet-
ter patient education and easier access to specialist care and 
diagnostic testing were seen as top solutions. Referrals from 
primary to secondary care were considered particularly 
problematic and likely to cause diagnostic delays. Many 
suggestions were synergistic or interrelated, and focused 
on common themes, eg, symptom awareness, care conti-
nuity, consultation length etc. This agreement among the 
identified suggestions reaffirmed the importance of certain 
priorities in the North West London context and conveys 
a clear message where action is needed. While all identified 
problems and solutions are important and revealing, their 
prioritization can support development of customised, lo-
cally–relevant policies in the context of limited health care 
means.
Clinicians in our study considered patient delays (due to 
symptom unawareness, late or emergency patient presen-
tation and lack of personal GP) a key problem, more likely 
to affect lower socio–economic groups. This corresponds 
to the surveys showing that awareness of cancer warning 
signs is low, especially among young men and lower socio-
economic groups [26,27]. In addition, almost a quarter of 
all cancer patients in England present as emergencies, often 
with the later stage of cancers and poorer outcomes [28]. 
Research shows that poor care continuity, a major problem 
in our study, hinders timely cancer diagnosis, especially in 
patients with complex cancer presentation and comorbid-
ities [29,30]. Raising patient awareness through public 
campaigns, a key solution identified in our study, has been 
associated with better recognition of symptoms and GP at-
tendance among patients as well with earlier stage lung 
cancer diagnosis [31,32].
In our study, better adherence to referral guidelines and a 
quicker access to diagnostic investigations were seen as the 
top priorities. This is consistent with the recent findings 
showing that the introduction of “urgent referrals” (seeing 
a specialist within 2 weeks of presenting to a GP) via Na-
tional Institute for Health and Care Excellence (NICE) can-
cer guidelines in 2005 was associated with earlier cancer 
diagnosis and better patient outcomes [33,34]. And yet, 
there are still large variations in GP cancer referral rates re-
vealing substantial differences in individual GP thresholds 
for referring symptomatic patients [35]. Furthermore, in-
stead of mandated “urgent referral”, some patients receive 
time–consuming diagnostic workup in the primary care 
setting, leading to later referral for specialist assessment 
[36]. In our study, clinicians considered rapid referrals to 
hospitals for certain patients as most likely to save lives 
which is in fitting with the recent addition of “very urgent 
referrals” (seeing a specialist within 48 hours of presenting 
to a GP) to the updated NICE cancer guidelines [37].
Strengths and limitations
PRIORITIZE is a timely, cost–effective and straightforward 
answer to calls for engagement of health care staff in patient 
Figure 5. Comparison 
of problems and 
solutions related to 
delayed diagnosis in 
cancer care in terms of 
the diagnostic process 
breakdown point.
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safety priority–setting [12]. While existing health care pro-
vider surveys on delayed diagnosis define priorities accord-
ing to their frequency [38,39], PRIORITIZE employs sev-
eral additional relevant and well–defied prioritization 
criteria such as severity, equity, economic impact and fea-
sibility. Given the regional inequalities in the UK’s cancer 
care and diagnosis, “one–size–fits–all” approach to devel-
opment of safety policies and initiatives is unlikely to be 
successful. PRIORITIZE enables identification of local pri-
orities and implementation of tailored patient safety inter-
ventions and policies.
The response rate in our study was low response which nay 
have affected the generalizability of our findings. However, 
the number of participants in our study corresponds to 
those in other priority setting exercises involving health 
care professionals or employing the CHNRI methodology 
[40–44]. Furthermore, physician surveys, especially those 
containing open–ended questions and focusing on sensi-
tive topics, are challenging and in general yield low re-
sponse rates [45–47]. To boost the response rate, surveys 
of hospital staff on patient safety in general necessitate lead-
ership engagement, intense campaigning, assurance that 
the employees’ feedback will be impactful etc. [48]. Sur-
veys in general recruit a self–selected sample and the par-
ticipants in our study potentially differed from those who 
did not take part in this study. Although our findings mir-
ror the relevant literature and the participants had the same 
eligibility criteria by being a cancer care provider in North 
West London, there may have been other, unmeasured bi-
ases. As most of the participants were oncology consultants 
or hospital–based trainees, this may have also influenced 
the choice and ranking of priorities.
While our findings are revealing, this approach is at an ear-
ly stage and could be improved, eg, providing examples to 
guide specificity of responses (eg, error producing condi-
tions, errors and adverse events), increasing the response 
rates or enabling longitudinal data collection. PRIORITIZE 
also provides opportunities for different types of analysis, 
inclusion of diverse prioritization criteria (eg, urgency, im-
pact, affordability, execution risk, sustainability etc.) and 
recruitment of both health care professionals and patients.
Implications for practice and policy
Delayed diagnosis of cancer has been recognized as the key 
reason for the UK’s lower cancer survival rates. Clinician-
identified priorities for a timely cancer diagnosis in our 
study focused on public awareness, patient education and 
access to specialist care and diagnostic testing. Using a bot-
tom–up approach, in which clinicians drive change, we 
collated concrete, locally–relevant and affordable sugges-
tions to inform the health care policy on patient safety. 
Many suggestions showed agreement underscoring the im-
portance of certain priorities. The Patient Safety Board as-
sembled priorities that were synergistic or inter–related (eg, 
improving adherence to referral guidelines, improving re-
ferral and follow up processes to ensure referrals are not 
lost, ensuring sufficient staff available to deal with referrals, 
improving the quality of information in patient referrals) 
to address them with a focused and concerted effort. Our 
findings are now being used to guide the Imperial College 
Health Partners’ work on the Medicines Optimisation in 
North West London.
Research shows that clinicians often feel excluded from the 
development of patient safety policies [49], avoid incident 
reporting due to lack of anonymity or time [50] and are fre-
quently victimised when pointing out safety issues [51]. PRI-
ORITIZE allows transparent, easy reproducible and anony-
mous voicing of concerns, suggestions and ideas from many 
health care providers. It triggers staff feedback and involve-
ment, enables evaluation of the organizational culture and 
the frontline staff views on the locally–relevant patient safety 
priorities and ultimately aligns the polices with clinicians’ 
feedback. It also ensures staff calibration, ie, a comparison 
between the physician’s self–assessment and external overall 
evaluation of the health care system’s and the organisational 
safety threats. We propose exploring weather this priority–
setting exercise could be included into the annual staff ap-
praisal process to detect clinicians’ perspective on the weak-
nesses in diagnostic processes in different settings. As a 
system–wide initiative, PRIORITIZE could increase the 
awareness of patient safety threats, improve the organisa-
tional culture, allow country–wide comparison and imple-
mentation of locally tailored–interventions.
CONCLUSIONS
Clinicians proposed a wide range of implementable, afford-
able and concrete suggestions for timely cancer diagnosis. 
The top ranked priorities focused on raising public aware-
ness, patient education as well as better access to specialist 
care and diagnostic testing. The identified suggestions fo-
cused mostly on the delays during referrals from primary 
to secondary care. While all identified problems and solu-
tions are noteworthy and revealing, their ranking can serve 
as an aid to policy makers and commissioners of care in 
prioritization of scarce health care resources. PRIORITIZE 
is a is highly feasible, informative and scalable priority–set-
ting approach, and merits wider exploration with a view of 
becoming part of a routine pro–active and preventative sys-
tem for patient safety assessment.
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